SPARCL1 and lung carcinoma: In contrast, NFKBIA, PSME3, SPARCL1, CCL15, and APOA1 did not return established entries under these filters and at the time of query, indicating that, within IPA, they are not currently categorized as clinical lung cancer biomarkers.